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Lipoic Acid in the Field of Dermatology 
(Prof. aγzd Dir巴 ctoγ ofDermatology， School of Medicine， Chiba Univeγsity) 
KATSU TAKENOUCHI M. D. 
(Received for ρublication， November 10， 1962) 
It is well known that lipoic acid is the coenzyme which catalyzes the oxidation of 
pyruvate and αketoglutealacid， and that it is concerned in the important reaction in the 同 
TCA cyc1 e. It is also known that its -SS and -SH types (its disul:fi de and dihydrolipoic 
acid) are reversible with each other. Attention has been called to the signi:fi cance of the 
lipoic acid metabolism in skin diseases， and we have had under way at our department 
a program for investigation into it. The report which 1 am going to make is summarized 
in Tab. 1. 
The accum ulation of pyruvate is a phenomenon frequently observed in patients with 
skin diseases. The results of our investigations show that 38% of the patients with 
Tab. 1. 
1. Effects of the administration of lipoic 
acid on 
a) 	blood pyruvate level， 
b) 	disturbed liver function， 
c) oxygen consumption of the skin 
slices in patients with skin diseases， 
2. Distribution of 35S・ labelled lipoic acid 
in the skin， 
3. Amounts of the acid excreted in the 
Urine， 
4. Loading test of 
a) 	lipoic acid， 
b) 	35S-1abelled lipoic acid 1n healthy 
persons and dermatoses， 
5. Treatment of dermatoses with lipoic 
acid. 
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Fig. 1 Improved blood level of pyruvate 
following oral administration of 
lipoic acid. 
eczema studied by us had abnormally high 
blood pyruvate levels， whi1 e 30% of them 
had abnormally low blood levels of thiamine 
which 1S concerned m the metabolism of 
pyruvate. The amount of pyruvate in the 
blood is generally increased in patients with 
eczema and dermatoses. Changes in blood 
pyruvate levels in these patients were studied 
by administering them with 25 mg of lipoic 
acid. す he resu1ts obtained were given in 
Fig. 1. It w i1 be seen that the amount of 
pyruvate began to show a gradual decrease 
about a week after administration， returning 
to normal level in 2 to 3 weeks following 
administration. 
It has been demonstrated that lipoic acid 
has action of protecting liver functions. This 
action seems to be of value in the treatment 
of skin diseases. Study was made of the 
e妊 ectof the acid on 40 patients with derma-
toses who showed evidence of disturved liver 
functions. The results， which are given in 
Fig. 2， show that the administration of the 
acid led to normalization of the liver func-
tions (jaundice index， Gross and Cobalt 
tests). 
Lerner and others have described the TCA 
cyc1e in the skin. Tab. 2 shows， that the 
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oxygen consumption of the skin with eczerna. The 
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samples of skin from normal， healthy persons， rat's 
h
Fig.2 Amounts and days of 
of pyruvate system in the skin of patients withtreatment of Lipoic acid 
administered for the im. eczema， and that lipoic acid plays a role in this 
provement of disturbed metabolic process. According to our investigations， 
liver functions. the amount of lipoic acid in the skin ofaxi1l ary 
Tab.2. Oxygen Consumption of the Slices of Skin， Liver and Cerebrum 
following the Addition of 100 r of Li poic acid. 
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- brain and liver， and guinea pig's .brain did not show 
this increase in oxygen consumption when the acid 
was added to them. This observation seems to in--lm
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dicate that there are disturbances of the metabolism 
seems to show that lipoic acid is concerned in metabolic processes not only in. the liver 
but also in the skin. 
Tab. 3 indicates that the amount of lipoic acid exc:reted in the urine ranged from 10 to 
20r・ Insuch serious cases as 20 and 21 listed in the Table， there was no excretion of 
the acid in the urine. In Case 21， itwas not until the high fever (390 C) fell to normal 
and symptoms were relieved that 10 to 15 rof lipoic acid was excreted in the urine. This 
slices fo the tissues 
Normal skin 
Skin from ecze町 la
グ、 lipoicacid added 
123 
4. 
5. 
6. 
7. 
8. 
9. 
Fig. 3 
cortex of cerebrum of maus 
1/ lipoic acid added 
cortex of cerebrum of guineapig 
ヶ lipoicacid added 
liver of maus 
1/ lipoic acid added 
6---A intestines.-ー・ liver 
0---0 skin 
x._._..)c kidneys 
0------0 musc1 e 
企{ー...... heart 
No.of cases Q02μ/l/hourexamined 
5 ，.21. 1. 4 
15 1. 0，_ 1. 6 
15 ，.41. 1. 6 
6 13.0，. 15.0 
3 14.0 15.0 ，_
4 12.0，. 14.0 
3 13.0，. 14.0 
3 10.0，. 11. 0 
3 1O .0 11.0 ，_ 
fossa in normal， healthy persons was in the 
range 0.05 to 0.1 r. while the amount of 
thiamine was 0.5 r. 
Changes in the amount of lipoic acid in 
the body of mice were studied 1 to 72 hours 
after intraperitoneal injections of 35S-1abelled 
lipoic acid. The results， which are given in 
Fig. 3， show that the amount detected in 
the skin， which was about 15 r 1 hour after 
injections， gradually decreased with time， 
and there sti1l was about 0.4 r 96 hours later. 
On the contrary， the amount detected in the 
liver was about 30 r 1 hour after injections， 
and 1 r 96 hours later. This observation 
[Q02 (average) 
1. 2 
1. 4 
1. 6 
14.4 
14.0 
13.0 
13.0 
10.0 
10.0 
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Tab. 3. Daily Urinary Excretion of 
Lipoic Acid. 
Cases !JNoZdLdil a da的ily町 veraegtme
1. x-ray derm. 10 24.5 
2. ecz. univ. 10 19.9 
3. vasculitis 12 10.1 
4. Behcet's dis. 9 12.0 
5. leucaemia cutis 3 28.1 
6. parapsoriasis 9 14.5 
7. spont. gangran 10 11.7 
8. ecz. pap 10 9.4 
9. vulv. carcinom 3 6.3 
10. hard naevus 7 10.7 
.11. atopic derm. 10 4.1 
12. ichtyosis sim. 9 13.0 
13. num. ecz. 6 9.0 
14. cheilitis 6 7.8 
15. drug eruption 5 13.0 
16. Hodgkin dis. 6 6.5 
17. purpura sin. 5 9.8 
18. dermat. herpetif. 8 7.4 
19. a州 c derml 6 4.8 
20. moniItasis prof.? 18 1.65 
21.puitrInp1 ura(medi，| 14 0.8astinal tumor) 
case Urinary Lipok acid (l1 g) 
men 1 2 2 3 1 1 
wamen 1 3 7 15 6 3 1 2 
ta tal 1 1 3 9 7 9 3 2 1 2 1 1 
% 2.5 2.5 7.522.517.522.57.5 5 2.5 5 2.5 2.5 
is considered to be due to acceleration of 
the consumption of the acid in the body. 
Incidentally， Case 20 died of leucaemic 
pupura， with no excretion of the acid in 
the urine ti1l the last day. 
The serum lipoic acid concentration in 
40 patients with skin diseases ranged from 
45 to 13 mr /cc. 
For the purpose of obtaining information 
on the lipoic acid metabolism， we at・ 
tempted a loading test. The acid was 
given intravenously to humans and rabbits 
and the amount excreted in the 24 hours 
urine was measured. It was found out 
that 99% was excreted within 2 hours. 
So it was assumed that estimation of the 
lipoic acid excreted in the 2-hour urine 
would serve purpose of the present ex-
periments. 
The amount of the acid excreted in the 
2-hour urine following intravenous in-
jections of 10 mg. of lipoic acid to 40 
normal， healthy persons was， as is shown 
in Fig. 4， in the range 11 to 35 r (about 
0.2% of the loaded dose)， in 75% of them. 
On the contrary Fig. 5 indicates that the 
average value in 49 patients with eczema 
was markedly smaller than that in normal 
persons. Whereas those who excreted less 
than 10 r of the acid in the 2-hour urine 
accounted for only 5% of normal persons， に 
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the宣 gurefor patients with eczema was 
38%. 
When the loading tests were performed 
5 10 15 勾~ a ~ ~ ~ W fi 00 E W in 249 patients with eczema and other 
Urinary Lipoic acid 
Fig. 4 Urinary Lipoic Acid after Injection skin diseases， abnormally low values were 
of 10 mg of the Acid in Heaethy found in 22% of them (Tab~ 4). The 
Subjects. 
proportions'of those who showed abnormal-
ly low excretion of the acid were: 17% in contact dermatitis， 30% in pigmentary anomaly 
and 26% in alopecia areata， besides 38% in eczema which was presented previously. The 
results obtained in suppurative diseases， psoriasis and angitis， which were 40， 20 and 33% 
respectively， seem to be worthy of note， in spite of the paucity of the cases examined. 
The abnormally low excretion of lipoic acid seen in these patients would seem to be due 
to its beeing consumed by metabolic disturbance in the skin and the liver. 
As stated previously， the conjugated .form which exist in the body was not estimated by 
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Fig. 5 Urinary Lipoic Acid after 1njection 
of 10 mg of the Acid in patients 
with eczema. 
bioassay. Healthy， normal persons were 
injected intravenously with 5 mg of 35S_ 
labelled lipoic acid， and the amount ex・ 
creted in the urine was measured in se-
quence. As is shown in Tab. 5， 91 to 99% 
of the acid was excreted in the 24-hour 
urine， with an excretion peak at the 2nd 
hour. 
Similar experiments using 35S・labelled 
lipoic acid carried out in 7 patients with 
eczema showed a maked decrease in the 
excretion of the acid， as was the case with 
the experiments by bioassay (Tab. 5). 
When compared with normal， healthy 
persons， 5 out of 7 patients with eczema 
Tab. 4. Loading Tests of Li poic Acid in 
various Skin Diseases. 
% of cases 
Cases C蹴~ed I印刷 ngexamined Iless than 
10μg 
1. normal control 40 5.0 
2. ecz. acut. & subacut. 49 38.7 
3. ecz. num. 7 14.2 
4. ecz. chron. 14 7.0 
5. dermat. ven. 23 17.3 
6. urtic. chr. 13 7.6 
7. fruncle & folliculitis 5 40.0 
8. acne vulg. 9 22.2 
9. psoriasis vulg. 
10. keratodermia. 
10 20.2 
4 。 
26.611. alop. area. 
12. chloasma 
15 
28.57 
13. leucoderma vulg. 13 30.7 
14. dermatomycosis 10 10.0 
15. pruitus cut. 3 
16. vasculitis 6 33.3 
17. seborrhea sicca 4 
18. cheilitis 3 
19. erythematodes disc. 2 
20. others 12 16.6 
total 249 22.0 
。 
。。。
 
had no excretion peak at the 2nd hour， with the curve being low and flat for the period 
from 30 minutes to 6 hours after injections. 1t is worthy of note that the decreased serum 
protein (6 gm percent) and disturbances of the liver functions (as evidenced by the B. S. P.， 
Cobalt and C. C. F.-tests) were associated with the decreased excretion of lipoic acid in 
the urine in these patients. 
1n view of these observations， itmight be said for certain that the major propotion of 
Tab. 5. Excretion of 35S-Radiometabolites in Urine following Injection of 
35S・ labelledLipoic Acid in normal and eczema persons. 
Cases Li ver function 品E己主自民 E由凶il1sEzE京，Z』ロ。2 ち~
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total 
3 L04 、ぷh excretion 
寸小~ % 
.23
1 … al c叫 al I normal 7.0 1.6 
2. / normal 7.0 10.4 
3. ecz. univ. normal 6.1 13.5 
4. ecz. num. 土 6.9 10.9 
5. erythroderm. + 
+ 
+ 
6.2 12.8 
6. ecz. univ. 7.0 10.1 
7. ecz. univ. 6.1 3.0 
8. ecz. univ. 十 6.0 11. 3 
9. ecz. univ. + 8.4 
24.5127.8 
16.3 29.3 
13.5 24.6 
9.9 23.8 
10.8 10.3 
7.4 11.8 
5.7 10.7 
11. 3 4.8 
8.4 6.8 
13.9 
15.8 
11.7 
4.1 
11.0 
13.5 
9.5 
5.0 
3.0 
9.2 
9.4 
6.2 
9.5 
5.8 
5.9 
2.6 
0.6 
6.7 
2.6 3.2 8.4 91. 5 
5.7 4.1 8.1 99.5 
4.4 3.0 10.2 87.4 
3.6 1.8 7.4 71.1 
3.9 1.9 8.1 64.7 
2.2 4.2 9.8 63.8 
8.9 3.1 12.0 55.5 
7.7 2.5 11.7 51. 6 
6.0 3.7 5.9 51. 3 
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Fig. 6 Radioautochromatogram of 35S 

Radiometabolites in Urinc 

Excreted in 3 Hours following 

injestion of 35S Lipoic Acid 

(5mg). 

lipoic acid is turned into the conjugated form in the body (Fig. 6-7). 
The administration of lipoic acid to 100 patients with various skin diseases resulted in 
a marked improvement in their conditions，as compared with 200 patients who served as 
contrls. 
(The report presented here have been read at XII th International Congress of Derma-
tology，which were held at Washington D. C.，U. S. A.， Sept. 14，1962.) 
Fig. 7 Radiochromatogram. 
